Journal of Surgical Research
Volume 141, Issue 1 , Pages 60-67 , July 2007

NMR Assessment of Me2SO in Decellularized Cryopreserved Aortic Valve Conduits

  • Eric J. Lehr, M.D.

      Affiliations

    • Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Surgery, University of Alberta Hospital, Dvorkin Lounge, 8440 - 112th Street, Edmonton, AB, Canada T6G 2B7.
    • ,
  • Sarah Hermary, B.S.

      Affiliations

    • Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Ryan T. McKay, Ph.D.

      Affiliations

    • National High Field NMR Centre, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Deryck N.H. Webb, B.Sc.

      Affiliations

    • National High Field NMR Centre, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Alireza Abazari, B.S.

      Affiliations

    • Department of Chemical and Material Engineering, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Locksley E. McGann, Ph.D.

      Affiliations

    • Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • James Y. Coe, M.D.

      Affiliations

    • Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Gregory S. Korbutt, Ph.D.

      Affiliations

    • Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • David B. Ross, M.D.

      Affiliations

    • Department of Surgery, University of Alberta, Edmonton, Alberta, Canada

Received 8 January 2007

References 

  1. Hufnagel CA. Preserved homologous arterial transplant. Bull Am Coll Surg. 1947;32:321
  2. Hufnagel CA. Aortic plastic valvular prosthesis. Bull Georgetown Univ Med Ctr. 1951;4:128
  3. Hammermeister KE, Sethi GK, Henderson WG, et al. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis (Veterans Affairs cooperative study on valvular heart disease). New Engl J Med. 1993;328:1289
  4. Lund O, Nielsen SL, Arildsen H, et al. Standard aortic St. Jude valve at 18 years: Performance profile and determinants of outcome. Ann Thorac Surg. 2000;69:1459
  5. Lupinetti FM, Warner J, Jones TK, et al. Comparison of human tissues and mechanical prostheses for aortic valve replacement in children. Circulation. 1997;96:321
  6. Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114:318
  7. Dignan R, O’Brien M, Hogan P, et al. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. J Heart Valve Dis. 2003;12:382
  8. Hogan P, Duplock L, Green M, et al. Human aortic valve allografts elicit a donor-specific immune response. J Thorac Cardiovasc Surg. 1996;112:1260
  9. Meyer SR, Campbell PM, Rutledge JM, et al. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. Eur J Cardiothorac Surg. 2005;27:554
  10. Meyer SR, Nagendran J, Desai LS, et al. Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg. 2005;130:469
  11. Kasimir MT, Weigel G, Sharma J, et al. The decellularized porcine heart valve matrix in tissue engineering: Platelet adhesion and activation. Thromb Haemost. 2005;94:562
  12. O’Brien MF, Stafford EG, Gardner MA, et al. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg. 1987;94:812
  13. Jashari R, Van Hoeck B, Tabaku M, et al. Banking of the human heart valves and the arteries at the European homograft bank (EHB)—overview of a 14-year activity in this International Association in Brussels. Cell Tissue Bank. 2004;5:239
  14. Lakey JR, Helms LM, Moser G, et al. Dynamics of cryoprotectant permeation in porcine heart valve leaflets. Cell Transplant. 2003;12:123
  15. Fahy GM. The relevance of cryoprotectant “toxicity” to cryobiology. Cryobiology. 1986;23:1
  16. Koizumi K, Tsutsumi Y, Yoshioka Y, et al. Antiangiogenic effects of dimethyl sulfoxide on endothelial cells. Biol Pharm Bull. 2003;26:1295
  17. Spoelstra FM, Kauffman HF, Hovenga H, et al. Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts. Am J Respir Crit Care Med. 2000;162:1229
  18. Crawford JM, Braunwald NS. Toxicity in vital fluorescence microscopy: Effect of dimethylsulfoxide, rhodamine-123, and DiI-low density lipoprotein on fibroblast growth in vitro. In Vitro Cell Dev Biol. 1991;27A:633
  19. Nagashunmugam T, Srinivas S, Shanmugam G. Effect of dimethyl sulfoxide on mouse embryo fibroblasts: Inhibition of plasminogen activator inhibitor deposition and interference with early events of serum-stimulated growth. Biol Cell. 1989;66:307
  20. Srinivas S, Sironmani TA, Shanmugam G. Dimethyl sulfoxide inhibits the expression of early growth-response genes and arrests fibroblasts at quiescence. Exp Cell Res. 1991;196:279
  21. Blau HM, Epstein CJ. Manipulation of myogenesis in vitro: Reversible inhibition by DMSO. Cell. 1979;17:95
  22. Wang H, Scott RE. Inhibition of distinct steps in the adipocyte differentiation pathway in 3T3 T mesenchymal stem cells by dimethyl sulphoxide (DMSO). Cell Prolif. 1993;26:55
  23. Dagia NM, Goetz DJ. A proteasome inhibitor reduces concurrent, sequential, and long-term IL-1 β- and TNF-α-induced ECAM expression and adhesion. Am J Physiol Cell Physiol. 2003;285:C813
  24. Cowling RT, Gurantz D, Peng J, et al. Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 β. J Biol Chem. 2002;277:5719
  25. Taylor MJ, Busza A. A convenient, noninvasive method for measuring the kinetics of permeation of dimethyl sulphoxide into isolated corneas using NMR spectroscopy. Cryo Lett. 1992;13:273
  26. Muldrew K, Sykes B, Schachar N, et al. Permeation kinetics of dimethyl sulfoxide in articular cartilage. Cryo Lett. 1996;17:331
  27. Guide to the care and use of experimental animals. Canadian Council of Animal Care; 1993;
  28. Meyer SR, Chiu B, Churchill TA, et al. Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res A. 2006;79:254
  29. Markley JL, Bax A, Arata Y, et al. Recommendations for the presentation of NMR structures of proteins and nucleic acids (IUPAC-IUBMB-IUPAB Inter-Union Task Group on the standardization of data bases of protein and nucleic acid structures determined by NMR spectroscopy). J Biomol NMR. 1998;12:1
  30. Crank J. In: The Mathematics of Diffusion. Oxford: Oxford University Press; 1975;p. 47–60
  31. Pollock GA, Hamlyn L, Maguire SH, et al. Effects of four cryoprotectants in combination with two vehicle solutions on cultured vascular endothelial cells. Cryobiology. 1991;28:413
  32. Hu JF, Wolfinbarger L. Dimethyl sulfoxide concentration in fresh and cryopreserved porcine valved conduit tissues. Cryobiology. 1994;31:461
  33. Carsi B, Lopez-Lacomba JL, Sanz J, et al. Cryoprotectant permeation through human articular cartilage. Osteoarthritis Cartilage. 2004;12:787

PII: S0022-4804(07)00243-0

doi: 10.1016/j.jss.2007.03.082

Journal of Surgical Research
Volume 141, Issue 1 , Pages 60-67 , July 2007

Article Tools

* Image Usage & Resolution